APO RESEARCH · REPORT
Latanoprost
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Product & engineering
Understand the product.
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Selected research
Market Structure
Global Latanoprost Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Read the full market overview
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
This report provides an overview of the global Latanoprost market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Latanoprost and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Latanoprost sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Latanoprost market size, projected growth trends, production technologies, key applications, and end-use industries.
Latanoprost Segment by Company
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Latanoprost Segment by Type
Brand Drug
Generic Drug
Latanoprost Segment by Application
Open-angle Glaucoma
Close-angle Glaucoma
Latanoprost Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latanoprost market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Latanoprost and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latanoprost.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Latanoprost market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latanoprost manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Latanoprost in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Latanoprost in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Brand Drug
- Generic Drug
Applications
- Open-angle Glaucoma
- Close-angle Glaucoma
Companies covered
- Pfizer
- Mylan
- Novartis
- Apotex
- Teva
- Taj Pharma
- CR Zizhu
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Latanoprost Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Latanoprost Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Latanoprost Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Latanoprost Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Latanoprost Market Dynamics
- 2.1 Latanoprost Industry Trends
- 2.2 Latanoprost Industry Drivers
- 2.3 Latanoprost Industry Opportunities and Challenges
- 2.4 Latanoprost Industry Restraints
3 Latanoprost Market by Manufacturers
- 3.1 Global Latanoprost Revenue by Manufacturers (2021-2026)
- 3.2 Global Latanoprost Sales by Manufacturers (2021-2026)
- 3.3 Global Latanoprost Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Latanoprost Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Latanoprost Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Latanoprost Manufacturers, Product Type & Application
- 3.7 Global Latanoprost Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Latanoprost Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Latanoprost Players Market Share by Revenue in 2025
- 3.8.3 2025 Latanoprost Tier 1, Tier 2, and Tier 3
4 Latanoprost Market by Type
- 4.1 Latanoprost Type Introduction
- 4.1.1 Brand Drug
- 4.1.2 Generic Drug
- 4.2 Global Latanoprost Sales by Type
- 4.2.1 Global Latanoprost Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Latanoprost Sales by Type (2021-2032)
- 4.2.3 Global Latanoprost Sales Market Share by Type (2021-2032)
- 4.3 Global Latanoprost Revenue by Type
- 4.3.1 Global Latanoprost Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Latanoprost Revenue by Type (2021-2032)
- 4.3.3 Global Latanoprost Revenue Market Share by Type (2021-2032)
5 Latanoprost Market by Application
- 5.1 Latanoprost Application Introduction
- 5.1.1 Open-angle Glaucoma
- 5.1.2 Close-angle Glaucoma
- 5.2 Global Latanoprost Sales by Application
- 5.2.1 Global Latanoprost Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Latanoprost Sales by Application (2021-2032)
- 5.2.3 Global Latanoprost Sales Market Share by Application (2021-2032)
- 5.3 Global Latanoprost Revenue by Application
- 5.3.1 Global Latanoprost Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Latanoprost Revenue by Application (2021-2032)
- 5.3.3 Global Latanoprost Revenue Market Share by Application (2021-2032)
6 Global Latanoprost Sales by Region
- 6.1 Global Latanoprost Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Latanoprost Sales by Region (2021-2032)
- 6.2.1 Global Latanoprost Sales by Region (2021-2026)
- 6.2.2 Global Latanoprost Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Latanoprost Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Latanoprost Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Latanoprost Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Latanoprost Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Latanoprost Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Latanoprost Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Latanoprost Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Latanoprost Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Latanoprost Revenue by Region
- 7.1 Global Latanoprost Revenue by Region
- 7.1.1 Global Latanoprost Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Latanoprost Revenue by Region (2021-2026)
- 7.1.3 Global Latanoprost Revenue by Region (2027-2032)
- 7.1.4 Global Latanoprost Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Latanoprost Revenue (2021-2032)
- 7.2.2 North America Latanoprost Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Latanoprost Revenue (2021-2032)
- 7.3.2 Europe Latanoprost Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Latanoprost Revenue (2021-2032)
- 7.4.2 Asia-Pacific Latanoprost Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Latanoprost Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Latanoprost Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Pfizer
- 8.1.1 Pfizer Company Information
- 8.1.2 Pfizer Business Overview
- 8.1.3 Pfizer Latanoprost Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Pfizer Latanoprost Product Portfolio
- 8.1.5 Pfizer Recent Developments
- 8.2 Mylan
- 8.2.1 Mylan Company Information
- 8.2.2 Mylan Business Overview
- 8.2.3 Mylan Latanoprost Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Mylan Latanoprost Product Portfolio
- 8.2.5 Mylan Recent Developments
- 8.3 Novartis
- 8.3.1 Novartis Company Information
- 8.3.2 Novartis Business Overview
- 8.3.3 Novartis Latanoprost Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Novartis Latanoprost Product Portfolio
- 8.3.5 Novartis Recent Developments
- 8.4 Apotex
- 8.4.1 Apotex Company Information
- 8.4.2 Apotex Business Overview
- 8.4.3 Apotex Latanoprost Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Apotex Latanoprost Product Portfolio
- 8.4.5 Apotex Recent Developments
- 8.5 Teva
- 8.5.1 Teva Company Information
- 8.5.2 Teva Business Overview
- 8.5.3 Teva Latanoprost Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Teva Latanoprost Product Portfolio
- 8.5.5 Teva Recent Developments
- 8.6 Taj Pharma
- 8.6.1 Taj Pharma Company Information
- 8.6.2 Taj Pharma Business Overview
- 8.6.3 Taj Pharma Latanoprost Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Taj Pharma Latanoprost Product Portfolio
- 8.6.5 Taj Pharma Recent Developments
- 8.7 CR Zizhu
- 8.7.1 CR Zizhu Company Information
- 8.7.2 CR Zizhu Business Overview
- 8.7.3 CR Zizhu Latanoprost Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 CR Zizhu Latanoprost Product Portfolio
- 8.7.5 CR Zizhu Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Latanoprost Value Chain Analysis
- 9.1.1 Latanoprost Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Latanoprost Production Mode & Process
- 9.2 Latanoprost Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Latanoprost Distributors
- 9.2.3 Latanoprost Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst